References
- Bain BJ. Bone marrow biopsy morbidity and mortality. Br J Haematol 2003;121:949–951.
- Richardson SE, Sudak J, Warbey V, et al. Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era. Leuk Lymphoma 2012;53:381–385.
- Cheng G, Chen W, Chamroonrat W, et al. Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eur J Nucl Med Mol Imaging 2011;38:1469–1476.
- Moulin-Romsee G, Hindié E, Cuenca X, et al. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 2010;37:1095–1105.
- Partridge S, Timoth A, O’Doherty M, et al. 2-Fluorine-18-fiuoro-2-deoxy-D-glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Ann Oncol 2000;11:1273–1279.
- Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?. Ann Oncol 2005;17:117–122.
- Naumann R, Beuthien-Baumann B, Reiß A, et al. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Br J Cancer 2004;90:620–625.
- Hutchings M, Loft A, Hansen M, et al. Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006;91:482–489.
- Cronin CG, Swords R, Truong MT, et al. Clinical utility of PET/CT in lymphoma. AJR Am J Roentgenol 2010;194:W91–W103.
- Even-Sapir E, Lievshitz G, Perry C, et al. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with non-Hodgkin lymphoma and Hodgkin's disease. Radiol Clin North Am 2007;45:697–709.
- Parker A, Bain B, Devereux S, et al. Best practice in lymphoma diagnosis and reporting. British Committee for Standards in Haematology, 2010. Available from: www.bcshguidelines.com/documents/Lymphoma_diagnosis_bcsh_042010.pdf
- Bain BJ. Bone marrow trephine biopsy. J Clin Pathol 2001;54: 737–742.
- Trewhitt KG. Bone marrow aspiration and biopsy: collection and interpretation. Oncol Nurs Forum 2001;28:1409–1415.
- El-Galaly TC, d’Amore F, Mylam KJ, et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography–staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol 2012;30:4508–4514.
- Hine-Thomas MR, Howard SC, Hudson MM, et al. Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin's lymphoma. Haematologica 2010:95:1691–1696.
- Meller J, Sahlmann CO, Scheel AK. 18F FDG PET and PET/CT in fever of unknown origin. J Nucl Med 2007;48:35–45.
- Pakos EE, Fotopoulos AD, Ioannidis JP. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma:a meta-analysis. J Nucl Med 2005;46:958–963.